| Microbiota in health and diseases K Hou, ZX Wu, XY Chen, JQ Wang, D Zhang, C Xiao, D Zhu, JB Koya, ... Signal transduction and targeted therapy 7 (1), 1-28, 2022 | 857 | 2022 |
| Erdafitinib antagonizes ABCB1-mediated multidrug resistance in cancer cells W Feng, M Zhang, ZX Wu, JQ Wang, XD Dong, Y Yang, QX Teng, ... Frontiers in oncology 10, 955, 2020 | 36 | 2020 |
| Discovery of potent inhibitors against P-glycoprotein-mediated multidrug resistance aided by late-stage functionalization of a 2-(4-(pyridin-2-yl) phenoxy) pyridine analogue Y Ma, D Yin, J Ye, X Wei, Y Pei, X Li, G Si, XY Chen, ZS Chen, Y Dong, ... Journal of Medicinal Chemistry 63 (10), 5458-5476, 2020 | 30 | 2020 |
| Overexpression of ABCC1 confers drug resistance to betulin XY Chen, Y Yang, JQ Wang, ZX Wu, J Li, ZS Chen Frontiers in oncology 11, 640656, 2021 | 27 | 2021 |
| NVP-CGM097, an HDM2 inhibitor, antagonizes ATP-binding cassette subfamily B member 1-mediated drug resistance M Zhang, XY Chen, XD Dong, JQ Wang, W Feng, QX Teng, Q Cui, J Li, ... Frontiers in oncology 10, 1219, 2020 | 18 | 2020 |
| Natural product as substrates of ABC transporters: a review XY Chen, JQ Wang, Y Yang, J Li, ZS Chen Recent patents on anti-cancer drug discovery 16 (2), 222-238, 2021 | 17 | 2021 |
| Qigesan inhibits esophageal cancer cell invasion and migration by inhibiting Gas6/Axl-induced epithelial-mesenchymal transition L Kong, X Lu, X Chen, Y Wu, Y Zhang, H Shi, J Li Aging (Albany NY) 12 (10), 9714, 2020 | 9 | 2020 |
| Association of lung-intestinal microecology and lung cancer therapy LY Kong, XY Chen, X Lu, Q Caiyin, DH Yang Chinese Medicine 18 (1), 37, 2023 | 8 | 2023 |
| Nivolumab and relatlimab for the treatment of melanoma. XY Chen, YD Li, Y Xie, LQ Cao, CR Ashby Jr, H Zhao, ZS Chen Drugs of Today (Barcelona, Spain: 1998) 59 (2), 91-104, 2023 | 6 | 2023 |
| Chinese Medicine formula siwu-yin inhibits esophageal precancerous lesions by improving intestinal flora and macrophage polarization HJ Shi, XY Chen, XR Chen, ZB Wu, JY Li, YQ Sun, DX Shi, J Li Frontiers in Pharmacology 13, 812386, 2022 | 6 | 2022 |
| Multidrug resistance transporters P-gp and BCRP limit the efficacy of ATR inhibitor ceralasertib in cancer cells XY Chen, ZX Wu, JQ Wang, QX Teng, H Tang, Q Liu, ZS Chen, W Chen Frontiers in Pharmacology 15, 1400699, 2024 | | 2024 |
| Microbiota in health and diseases H Kaijian, W Zhuo-Xun, C Xuan-Yu, W Jing-Quan, Z Dongya, ... Signal Transduction and Targeted Therapy 7 (1), 2022 | | 2022 |
